🔎 Trials Near Me

Gara Jalqabaatti › Kansara Metastatikii › California › Mountain View

Qorannoo klinikaalii Kansara Metastatikii Mountain View, CA keessatti

Qorannoo 25 Kansara Metastatikii f Mountain View fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Stanford Cancer Institute Palo Alto, Palo Alto · Miili 5 fagaatti
  • VA Palo Alto Health Care System, Palo Alto · Miili 5 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564377

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 1/2
  • Stanford, Palo Alto · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05287945

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Namoota walitti qabaa jiraSadarkaa 2/3
  • Stanford Cancer Center, Palo Alto · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06943755

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07222800

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Stanford Medicine, Palo Alto · Miili 5 fagaatti
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT05118789

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Namoota walitti qabaa jiraSadarkaa 1
  • Stanford Cancer Institute, Stanford · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06915753

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Namoota walitti qabaa jiraSadarkaa 1
  • Stanford University Medical Center, Stanford · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07114601

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Stanford Women's Cancer Center, Palo Alto · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213804

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Namoota walitti qabaa jiraSadarkaa 3
  • Stanford Cancer Center, Palo Alto · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07174336

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Stanford Cancer Institute, Stanford · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06128551

Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.

Namoota walitti qabaa jiraSadarkaa 2
  • Stanford University, Palo Alto · Miili 5 fagaatti
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT07594431

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Research Site, Palo Alto · Miili 5 fagaatti
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07647328

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Stanford Cancer Institute (SCI), Stanford · Miili 5 fagaatti
Umuriin 18 fi ol · Dubartoota · Haaromfame 03-Ful-2026 · NCT04802759

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Namoota walitti qabaa jiraSadarkaa 1
  • Stanford Medicine Cancer Center, Stanford · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT05614739

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Stanford Cancer Institute, Stanford University, Palo Alto · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05919264

Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

Namoota walitti qabaa jiraSadarkaa 3
  • Stanford University School of Medicine, Palo Alto · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT06173401

A Study of LY4175408 in Participants With Advanced Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • Stanford Medicine Cancer Center, Stanford · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Wax-2026 · NCT07046923

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Stanford Cancer Institute, Stanford · Miili 5 fagaatti
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT05384626

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 2/3
  • Stanford Health Care - Skin Cancer Program, Stanford · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Elb-2026 · NCT06947928

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Namoota walitti qabaa jiraSadarkaa 2/3
  • Stanford Cancer Institute, Palo Alto · Miili 5 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 02-Elb-2026 · NCT06581406

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Stanford Cancer Institute, Stanford · Miili 5 fagaatti
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT04119024

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Namoota walitti qabaa jiraSadarkaa 1
  • Stanford Cancer Institute, Stanford · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Gur-2026 · NCT06521554

Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology

Namoota walitti qabaa jiraQorannoo ilaalaa
  • VA Palo Alto Healthcare System, Palo Alto · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Mud-2025 · NCT07303725

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Stanford Cancer Institute, Palo Alto · Miili 5 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Mud-2025 · NCT05270213

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Stanford · Miili 5 fagaatti
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

Qorannoo Kansara Metastatikii magaalota biroo keessatti

Qorannoo biroo Mountain View keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.